Dallas-based biotech startup Colossal has raised hundreds of millions from venture capitalists, the CIA, and Peter Thiel to resurrect extinct animals. The company's approach uses genetic engineering rather than cloning ancient DNA.
Colossal's ambitions span woolly mammoths, Tasmanian tigers, and dire wolves—though the marketing term "de-extinction" oversimplifies the science. The startup doesn't recover lost creatures from fossilized DNA. Instead, it modifies living animals' genomes to recreate extinct species' traits.
The 2025 dire wolf reveal exemplified this strategy: the presented animals were gray wolves with edited genes, not recreated dire wolves. This genetic approach sidesteps technical barriers that make true cloning from ancient DNA impractical.
The venture has attracted serious backing, signaling investor confidence in synthetic biology applications. However, the gap between genetic modification and true species resurrection remains substantial. Colossal's work advances biotechnology capabilities while raising questions about ecosystem integration and project timelines.
The startup represents a growing sector betting that genetic engineering can solve extinction—even if the science differs sharply from popular perception.
AfterQuery, a startup selling coding and finance training data to AI labs, reached a $3.2 billion valuation, up from $300 million in April. The company is already profitable.
Empirik, an AI platform that predicts and prevents IT outages by analyzing system changes, has raised $21M in seed funding and officially spun out from Sequoia Capital as an independent company.
Wafer, an AI platform that optimizes open-source models for specific business workloads, secured $40M in Series A funding at a $200M+ valuation, according to The Information.
A former PG&E engineer launched a startup building digital maps of underground infrastructure. The company just secured $26 million in Series A funding to expand operations and streamline utility and construction work.